INVIVOSCRIBE INC.

In News

System, an Integrated Sample Preparation Platform that Standardizes and Streamlines Pre-Analytical Workflows - Business Wire

Business Wire - Apr 15, 2026

Invivoscribe® Expands IVDR Portfolio with IdentiClone® Dx IGH Assay Certification - Business Wire

Business Wire - Mar 26, 2026

Hitachi High-Tech and Invivoscribe partner to advance molecular diagnostics and precision medicine - PR Newswire

PR Newswire - May 09, 2022

Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide - Business Wire

Business Wire - Feb 05, 2026

Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia - Nature

Nature - Nov 24, 2025

Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemia - PR Newswire

PR Newswire - Jul 14, 2020

Invivoscribe Releases the LymphoTrack Dx TRB Assay as CE-Marked IVD Kit, Completing the NGS Clonality Suite for the MiSeq Platform - NTB Kommunikasjon

NTB Kommunikasjon - May 15, 2018

Invivoscribe® Releases LeukoStrat® CDx FLT3 Mutation Assay as CE-marked IVD Assay Kit - Koreabizwire

Koreabizwire - Aug 01, 2017

Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AML - PR Newswire

PR Newswire - Aug 16, 2022

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment